Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3184 of 6351
-
Could a High-Fat diet help tame eating disorder thoughts?
Symptom relief Recruiting nowThis study will investigate the effects of therapeutic ketogenic diet (TKD) on eating behavior including drive to restrict, body dissatisfaction, mood and anxiety in individuals with anorexia nervosa who have been weight normalized (body mass index of 17.5 or greater) but continu…
Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 26, 2026 13:48 UTC
-
Gene therapy trial targets rare brain disease
Disease control OngoingThe objective of this randomized, double-blinded, placebo-controlled Phase 1 investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to the putamen in subjects with either a possible or probable diagnosis of Multiple System Atrophy.
Phase 1 • Sponsor: Brain Neurotherapy Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Virtual reality goggles ease colonoscopy pain, study finds
Symptom relief CompletedColonoscopy is a primary method of examining colorectal diseases. However, the procedure is associated with embarrassment, pain, and discomfort. This make patients less willing to be subjected to repeat surveillance colonoscopies. Performing colonoscopy under sedation is widely u…
Sponsor: Max Healthcare Insititute Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New hope for kids with Drug-Resistant TB: pretomanid dose study completed
Disease control CompletedThe purpose of the study is to evaluate the pharmacokinetics (PK), safety, tolerability, and acceptability of a single dose of pretomanid, added to an optimized background tuberculosis treatment regimen (OBR), in children with rifampicin-resistant tuberculosis (RR-TB) with or wit…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New radioactive therapy shows promise in early trial for tough cancers
Disease control CompletedThis proposal is a phase I, open-label study of a 4-Dose Regimen of Escalating Doses of 177Lu-LNC1004 Injection in patients with recurrent or metastatic, fibroblast activation protein-positive solid tumors. In the clinical development, we aim to demonstrate the following: * 177…
Phase 1 • Sponsor: Yantai LNC Biotechnology Singapore PTE. LTD. • Aim: Disease control
Last updated Jun 26, 2026 15:15 UTC
-
New triple therapy shows promise for blood cancer patients
Disease control Recruiting nowThis phase Ib trial tests the safety and effectiveness of tafasitamab, acalabrutinib, and obinutuzumab in treating patients with previously untreated chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). CLL and SLL are types of cancer that develops from a spec…
Phase 1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Battle of the bypass fixes: which procedure helps regain weight better?
Disease control OngoingThe goal of this clinical trial is to compare two variations of the same procedure used to assist with weight loss in patients who have a history of Roux-en-Y gastric bypass who have experienced weight regain. The procedure being studied is called the Transoral Outlet Reduction (…
Sponsor: Stephen Firkins • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Scientists hunt for blood clues to make nut allergy treatment safer
Knowledge-focused OngoingPeanut and tree nuts belong to the main elicitors of pediatric food allergy and are the main cause of near fatal reactions in children requiring emergency management. Oral immunotherapy has emerged as an alternative treatment option for the management of food allergies, to enhanc…
Sponsor: Luxembourg Institute of Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Physio first: new model aims to ease hip and knee pain
Symptom relief CompletedThis is a cluster randomized controlled trial to to evaluate the individual and health system impacts of implementing a new physiotherapist-led primary care model for hip and knee pain in Canada.
Sponsor: Queen's University • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Brain-Training app aims to ease back pain without pills
Symptom relief Recruiting nowThe purpose of this study is to learn more about improving the quality of treatments for people who have chronic low back pain. Participants will complete interviews with Duke researchers at four different time points: the beginning of the study, at 3 months, at 6 months, and at …
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Can dupixent calm mysterious skin flares?
Disease control CompletedThis research is studying a drug called dupilumab to learn about its safety and its effect as a treatment for participants with dermal hypersensitivity reaction. This study will help better understand why and how dermal hypersensitivity reaction occurs and how dupilumab might hel…
Phase 4 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug HCB101 enters human trials for tough cancers
Disease control Recruiting nowThe purpose of this study is to find out whether IV injection of HCB101 is an effective treatment for different types of advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma and what side effects (unwanted effects) may occur in subjects aged 18 years old and abov…
Phase 1 • Sponsor: FBD Biologics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Free FIT kits at DMV aim to slash colorectal cancer in african americans
Prevention Recruiting nowAfrican Americans face racial disparities in colorectal cancer (CRC), with lower screening rates and higher incidence and mortality rates. To address this gap and improve CRC screening rates, investigators aims to recruit a total of 1,200 African American participants aged 45-75 …
Sponsor: University of Nebraska • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
New patch aims to stop bleeding faster in keyhole surgery
Disease control CompletedThis is a pre-market, prospective, randomized (1:1), multicenter, pivotal clinical investigation. The purpose of this investigation is to determine the clinical performance of GATT-Patch as compared with SURGICEL® Original for the management of minimal, mild, or moderate bleeding…
Sponsor: GATT Technologies BV • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Exercise and diet combo takes on fatty liver inflammation
Disease control Recruiting nowThe aim of the study is to estimate the effectiveness of two different exercise programs combined with the Mediterranean diet versus diet alone on inflammatory status in subjects aged 18-65 years with obesity (BMI\>30) and Non-Alcoholic Fatty Liver Disease (NAFLD) (CAP \>248 dB/m…
Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Fiber fix? study tests if a simple supplement boosts arthritis Drug's power
Disease control CompletedFiber is the main source of energy for colonic bacteria and its consumption favorably modifies the composition of the microbiota in only a few days. Their fermentation in the colon releases short-chain fatty acids (SCFAs). Clostridiales contain many strains producing SCFAs. These…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo aims to tame CAR T-Cell side effects in leukemia
Disease control OngoingTo assess the feasibility of oral dasatinib pulses (3 consecutive days per week) during the first month following infusion of brexucabtagene autoleucel (Tecartus) in adults with relapsed or refractory B-cell acute lymphoblastic leukemia.
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Pain education may get people moving again
Symptom relief Recruiting nowProposing ways to effectively counter chronic low back pain through non-drug intervention is a major public health issue due to the prevalence and health costs of this condition. The back school (BS) is based on spinal economics and a biomechanical model. A convergence of evidenc…
Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New vibrating vest aims to make lung clearance easier for chronic lung patients
Symptom relief CompletedThis study will evaluate the effectiveness, safety, and tolerability of a novel wearable device, the ELECTROVEST, designed to improve airway clearance in patients with chronic respiratory diseases. The ELECTROVEST will integrate high-frequency chest wall oscillation (HFCWO) with …
Sponsor: Hospitales Universitarios Virgen del Rocío • Aim: Symptom relief
Last updated Jun 26, 2026 18:17 UTC
-
New drug combo shows promise in early cancer trial
Disease control CompletedThe purpose of this study is to evaluate the safety and tolerability of RO7496353 in combination with a checkpoint inhibitor (CPI) with or without standard-of-care (SOC) chemotherapy in participants with locally advanced or metastatic solid tumors such as non-small cell lung canc…
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC